The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

1. Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2014
Global Markets Direct’s, ‘Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2014’, provides an overview of the Collegium
Pharmaceutical, Inc.’s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Collegium Pharmaceutical, Inc.’s, complete with
comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It
also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s
team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated
with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking
ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides brief overview of Collegium Pharmaceutical, Inc. including business description, key information and facts, and its locations and
subsidiaries The report reviews current pipeline of Collegium Pharmaceutical, Inc.’s human therapeutic division and enlists all their major and minor
projects The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental
history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline
projects Latest company statement Latest news and deals relating to the Collegium Pharmaceutical, Inc.’s pipeline products
Reasons to buy
Evaluate Collegium Pharmaceutical, Inc.’s strategic position with total access to detailed information on its product pipeline Assess the growth potential
of Collegium Pharmaceutical, Inc. in its therapy areas of focus Identify new drug targets and therapeutic classes in the Collegium Pharmaceutical, Inc.’s
R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity
to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of Collegium Pharmaceutical, Inc. and exploit collaboration and partnership
opportunities Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan
mergers and acquisitions effectively by identifying the most promising pipeline of Collegium Pharmaceutical, Inc. Develop and design in-licensing and
out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Explore the
dormant and discontinued projects of Collegium Pharmaceutical, Inc. and identify potential opportunities in those areas Avoid Intellectual Property Rights related
issues
table Of Content
collegium Pharmaceutical, Inc. Snapshot
collegium Pharmaceutical, Inc. Overview
key Information
key Facts
collegium Pharmaceutical, Inc. - Research And Development Overview
key Therapeutic Areas
collegium Pharmaceutical, Inc. - Pipeline Review
pipeline Products By Stage Of Development
pipeline Products - Monotherapy
collegium Pharmaceutical, Inc. - Pipeline Products Glance
collegium Pharmaceutical, Inc. - Late Stage Pipeline Products
phase Iii Products/combination Treatment Modalities
collegium Pharmaceutical, Inc. - Early Stage Pipeline Products
ind/cta Filed Products/combination Treatment Modalities
preclinical Products/combination Treatment Modalities
discovery Products/combination Treatment Modalities
collegium Pharmaceutical, Inc. - Drug Profiles
oxycodone Er
product Description
mechanism Of Action
r&d Progress
oxymorphone
product Description
mechanism Of Action
r&d Progress
col-171
product Description
mechanism Of Action
r&d Progress
col-195
product Description
Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2014

2. mechanism Of Action
r&d Progress
col-196
product Description
mechanism Of Action
r&d Progress
milnacipran Hydrochloride
product Description
mechanism Of Action
r&d Progress
collegium Pharmaceutical, Inc. - Pipeline Analysis
collegium Pharmaceutical, Inc. - Pipeline Products By Target
collegium Pharmaceutical, Inc. - Pipeline Products By Route Of Administration
collegium Pharmaceutical, Inc. - Pipeline Products By Molecule Type
collegium Pharmaceutical, Inc. - Pipeline Products By Mechanism Of Action
collegium Pharmaceutical, Inc. - Recent Pipeline Updates
collegium Pharmaceutical, Inc. - Dormant Projects
collegium Pharmaceutical, Inc. - Locations And Subsidiaries
head Office
appendix
methodology
coverage
secondary Research
primary Research
expert Panel Validation
contact Us
disclaimer
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2014